Chester County News and Community Website
HARRISBURG, PA — Three generic drug manufacturers have agreed to antitrust settlements that include $1.05 million in payments to states and restrictions on future business practices, as Pennsylvania and 44 …
Generic Drugmakers Agree to $1.05 Million in Settlements Read More
WASHINGTON, D.C. — The Federal Trade Commission is urging a federal appeals court to reject Amgen Inc.’s argument that its acquisition of patent rights protecting the arthritis drug Enbrel is …
FTC Challenges Amgen’s Bid to Shield Enbrel Patent Deal Read More
EXTON, PA — ProRx Pharma said it expanded its operations, tripled production capacity, and entered new markets to meet growing demand for compounded medications.
Inside ProRx’s Rapid Expansion: Production Triples, Footprint Grows Read More EXTON, PA — ProRx Pharma launched a patented Liquid Nanoemulsion Delivery System that offers a needle-free alternative to injectable medications and, according to the company, positions ProRx as the only …
ProRx Bets on Needle-Free Nanoemulsions—Will Faster Absorption Win? Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Papzimeos (zopapogene imadenovec-drba), marking the first approved medical therapy for adults with recurrent respiratory papillomatosis (RRP), a rare …
FDA Approves First Immunotherapy for Rare Respiratory Papillomatosis Read More
WASHINGTON, D.C. — As part of President Trump’s Executive Order No. 14273, Lowering Drug Prices by Once Again Putting Americans First, the FTC, DOJ Antitrust Division, Department of Commerce, and …
FTC and DOJ Host Listening Sessions to Lower Drug Prices and Boost Competition Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the completion of its Biologics License Application (BLA) submission to the U.S. Food and Drug Administration (FDA) for MOLBREEVI, a potential treatment …
Savara Completes BLA Submission for MOLBREEVI to Treat aPAP Read More